NOEM

NOEM is not an operating company — it is a Delaware blank-check SPAC (incorporated 9/30/2021) that IPO'd on 11/22/2024, raising $69.0M placed into a trust account that held $72.1M as of 12/31/2025. There is no revenue in any year, and the entire FY2025 'profit' is an accounting artifact: net income of $1.65M was produced solely by $2.88M of interest earned on trust securities, while the actual operating business lost money (operating income -$646K, operating cash flow -$745K). The eye-catching '+62,679% net income growth' and the -1.61x liabilities/equity ratio are SPAC-structure noise, not signal — negative stockholders' equity (-$1.79M) reflects public shares carried as temporary equity subject to redemption, not balance-sheet distress.

What actually matters is the trust math and the clock. With ~6.9M public shares against a ~$72.1M trust, redeemable value is roughly $10.45/share — and the stock at $10.43 is trading essentially on top of that floor. That is the whole investment case: holders can redeem for their pro-rata trust cash, so downside is largely capped near $10.45, while upside depends entirely on management announcing an accretive business combination that the market rewards above trust. No target or deal is disclosed in the filing.